Avoid common mistakes on your manuscript.
Dear Editor,
A 63-year-old patient presented with abdominal pain. A computerized tomogram scan showed a gallbladder mass (Fig. 1a). A positron emission tomogram revealed additional FDG-avid lesions in the sternum, ribs, bilateral humeri, vertebral column, and pelvic bone (Fig. 1b). Magnetic resonance imaging confirmed vertebral lytic lesions (Fig. 1c). A serum protein electrophoresis showed a monoclonal band (IgA λ 16.2g/l), and he was referred for suspected plasma cell myeloma (PCM). A bone marrow biopsy, however, showed 19 % infiltration by monoclonal B cells, expressing CD20, but negative for CD3−, CD5, CD10, CD138, IgA, IgG, and IgM (Fig. 1d). These cells showed κ−light chain restriction (Fig. 1e, f). Staining with CD138 highlighted less than 1 % plasma cells, while the lymphoma cells do not express CD138. In view of the discrepancy, cholecystectomy was performed showing a plasmacytoma (Fig. 1g). The plasma cells were CD138 positive, CD20 negative, and also positive for cytoplasmic lambda chain and IgA, but negative for IgG, IgM, and κ−light chain restriction. (Fig. 1h, i). They also expressed CD56 and cyclin D1. The double pathology was treated with R-CEOP ×6 (rituximab, cyclophosphamide, epirubicin, vincristine, and prednisolone) together with maintenance with thalidomide and bortezomib (weekly × 16 doses) and radiotherapy to both humerus. A complete remission by radiological and serum immunofixation assessment was shown at 1 year. He refused an autologous stem cell transplantation (SCT). The clonal relationship between the two lesions was investigated by polymerase chain reaction using IgH VJ primers followed by cloning and sequencing, using DNA from the homogeneous plasmacytoma and microdissected lymphoma cells from the trephine biopsy [1]. This showed a direct relationship between the two B cell clones in terms of band size and sequence homology (Fig. 1j and k).
This case is interesting in terms of pathogenesis and treatment. In terms of pathogenesis, cases of concomitant B cell lymphoproliferation and plasma cell dyscrasia are rare and usually of independent clones [2]. The immunophenotyping and light chain expression do not suggest a common evolution from a lymphoplasmacytoid lymphoma. Our case is characterized by clonal homology but discordant light chain expression, immunophenotype, and morphology. Plasma cell myeloma with discordant light chain secretion is well documented [3]. Posttreatment switch in monoclonal protein may also occur after SCT [4]. More dramatically, changes in immunophenotype, morphology, and light chain expression in B cell malignancies after rituximab treatment are also recognized [1, 5, 6]. However, in our case, the clones occurred concomitantly and upfront in distinct cell lineages. This may theoretically result from plasma cell differentiation of the malignant B lymphocytes or a divergent evolution from a primordial B cell clone. Pools of malignant clonotypic B cells are known to exist in PCM patients [7]. In terms of treatment, a combination of lymphoma and PCM treatment seems to be effective in controlling both lesions with minimal overlap of toxicity. It is uncertain whether this patient may have survival benefit from an autologous SCT.
References
Au WY, Srivastava G, Wong KY, Chung LP, Ma SK, Wan TS et al (2004) Transformation of diffuse large B-cell lymphoma into pre-B acute lymphoblastic leukemia: clinicopathologic features and clonal relationship. Hum Pathol 35(7):900–903
Pantic M, Schroettner P, Pfeifer D, Rawluk J, Denz U, Schmitt-Graff A et al (2010) Biclonal origin prevails in concomitant chronic lymphocytic leukemia and multiple myeloma. Leukemia 24(4):885–890
Ando K, Yaguchi M, Okabe S, Miyazawa K, Ohyashiki K (2000) IgA-lambda/IgG-kappa biclonal myeloma in which two clones proliferated in individual sites. Intern Med 39(2):170–175
Zent CS, Wilson CS, Tricot G, Jagannath S, Siegel D, Desikan KR et al (1998) Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood 91(9):3518–3523
Hwang YY, Wong KY, Leung RY, Wong SH, Chan SC, Srivastava G et al (2009) Post-rituximab Burkitt transformation of PTLD: loss of CD20 expression accompanied by a switch in light-chain expression. Ann Hematol 9:9
Au WY, Wong K, So JC, Wan TS, Srivastava G, Liang R (2009) A unique case of B cell lymphoma relapsing as CD4/CD56 blastic neoplasm. Leuk Lymphoma 50:932–936
Conway EJ, Wen J, Feng Y, Mo A, Huang WT, Keever-Taylor CA et al (2009) Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry. Arch Pathol Lab Med 133(10):1594–1599
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Au, W.Y., Wai-Hung, L., Wong, K.Y. et al. Concomitant plasmacytoma and B cell lymphoma with discordant light chain expression but clonal identity. Ann Hematol 91, 1649–1651 (2012). https://doi.org/10.1007/s00277-012-1443-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-012-1443-0